Ursula Creutzig

16.2k total citations
217 papers, 7.6k citations indexed

About

Ursula Creutzig is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Ursula Creutzig has authored 217 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Hematology, 85 papers in Public Health, Environmental and Occupational Health and 57 papers in Molecular Biology. Recurrent topics in Ursula Creutzig's work include Acute Myeloid Leukemia Research (170 papers), Acute Lymphoblastic Leukemia research (83 papers) and Hematopoietic Stem Cell Transplantation (43 papers). Ursula Creutzig is often cited by papers focused on Acute Myeloid Leukemia Research (170 papers), Acute Lymphoblastic Leukemia research (83 papers) and Hematopoietic Stem Cell Transplantation (43 papers). Ursula Creutzig collaborates with scholars based in Germany, Netherlands and Austria. Ursula Creutzig's co-authors include Dirk Reinhardt, Gertjan J.L. Kaspers, Michael Dworzak, Martin Zimmermann, J. Ritter, Thomas Lehrnbecher, Martin Zimmermann, Jan Starý, M Zimmermann and Jochen Harbott and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Ursula Creutzig

212 papers receiving 7.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ursula Creutzig 5.2k 3.0k 2.5k 1.8k 900 217 7.6k
Michael Dworzak 3.6k 0.7× 3.0k 1.0× 1.2k 0.5× 1.2k 0.7× 654 0.7× 189 5.8k
Selina M. Luger 5.4k 1.0× 3.2k 1.1× 2.9k 1.2× 2.9k 1.7× 1.1k 1.3× 304 9.7k
Alan S. Gamis 3.1k 0.6× 1.7k 0.5× 1.6k 0.7× 1.1k 0.6× 561 0.6× 222 5.0k
Anjali S. Advani 3.5k 0.7× 3.0k 1.0× 1.6k 0.6× 2.9k 1.6× 1.2k 1.3× 298 7.1k
Dan Douer 3.0k 0.6× 1.6k 0.5× 2.9k 1.2× 818 0.5× 542 0.6× 192 5.7k
Meir Wetzler 5.0k 1.0× 1.9k 0.6× 3.0k 1.2× 2.1k 1.2× 2.1k 2.3× 245 8.6k
Joseph Brandwein 2.7k 0.5× 1.2k 0.4× 1.8k 0.7× 1.8k 1.0× 1.0k 1.1× 191 5.3k
Norbert Ifrah 7.3k 1.4× 2.8k 0.9× 3.9k 1.5× 3.5k 2.0× 1.7k 1.9× 231 11.4k
Norbert Vey 7.1k 1.4× 2.3k 0.8× 3.7k 1.5× 2.4k 1.4× 2.2k 2.5× 402 10.6k
Peter A. Cassileth 4.0k 0.8× 1.9k 0.6× 1.9k 0.7× 2.3k 1.3× 2.2k 2.4× 127 8.0k

Countries citing papers authored by Ursula Creutzig

Since Specialization
Citations

This map shows the geographic impact of Ursula Creutzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Creutzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Creutzig more than expected).

Fields of papers citing papers by Ursula Creutzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Creutzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Creutzig. The network helps show where Ursula Creutzig may publish in the future.

Co-authorship network of co-authors of Ursula Creutzig

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Creutzig. A scholar is included among the top collaborators of Ursula Creutzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Creutzig. Ursula Creutzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, M., Naghmeh Niktoreh, Uta Dirksen, et al.. (2025). Improved outcomes and treatment guidance in pediatric therapy-related AML: AML-BFM study group recommendations. Blood Advances. 9(11). 2831–2841. 1 indexed citations
2.
Rasche, Mareike, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2021). Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group. Cancers. 13(4). 789–789. 15 indexed citations
3.
4.
Abla, Oussama, Raul C. Ribeiro, Anna Maria Testi, et al.. (2017). Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Annals of Hematology. 96(9). 1449–1456. 27 indexed citations
5.
Tramsen, Lars, Emilia Salzmann‐Manrique, Konrad Bochennek, et al.. (2016). Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial. Journal of Clinical Oncology. 34(23). 2776–2783. 37 indexed citations
6.
Bachas, Costa, Gerrit Jan Schuurhuis, C. Michel Zwaan, et al.. (2015). Gene Expression Profiles Associated with Pediatric Relapsed AML. PLoS ONE. 10(4). e0121730–e0121730. 22 indexed citations
7.
Kaspers, Gertjan J.L., Martin Zimmermann, Dirk Reinhardt, et al.. (2013). Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group. Journal of Clinical Oncology. 31(5). 599–607. 152 indexed citations
8.
Creutzig, Ursula, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2013). Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood. 122(1). 37–43. 123 indexed citations
9.
Creutzig, Ursula, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2011). CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML‐BFM98 and 2004. Pediatric Blood & Cancer. 57(6). 986–992. 19 indexed citations
10.
Balgobind, Brian V., Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, et al.. (2011). Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica. 96(10). 1478–1487. 76 indexed citations
11.
Zimmermann, Martin, Manuela Germeshausen, Nils von Neuhoff, et al.. (2010). Granulocyte Colony-Stimulating Factor (G-CSF) Treatment of Childhood Acute Myeloid Leukemias That Overexpress the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated With a Higher Incidence of Relapse. Journal of Clinical Oncology. 28(15). 2591–2597. 47 indexed citations
12.
Hollink, Iris H.I.M., Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, et al.. (2009). Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood. 113(23). 5951–5960. 80 indexed citations
13.
Herold, Ralf, et al.. (2007). Stand und Bewertung der Strukturen und Ausstattung pädiatrisch-onkologisch-hämatologischer Kliniken. Klinische Pädiatrie. 219(6). 380–390. 1 indexed citations
14.
Cloos, Jacqueline, Bianca F. Goemans, Corine J. Hess, et al.. (2006). Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Leukemia. 20(7). 1217–1220. 140 indexed citations
15.
Creutzig, Ursula, et al.. (2006). Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML. Pediatric Blood & Cancer. 48(7). 651–662. 60 indexed citations
16.
Goemans, Bianca F., Ch. M. Zwaan, M Zimmermann, et al.. (2005). Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia. 19(9). 1536–1542. 174 indexed citations
17.
Lehrnbecher, Thomas, Toralf Bernig, Mitra Hanisch, et al.. (2005). Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia. 19(10). 1745–1750. 47 indexed citations
18.
Langer, Thorsten, Markus Metzler, Dirk Reinhardt, et al.. (2003). Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: Almost identical MLL breakpoints in therapy‐related AML after treatment without etoposides. Genes Chromosomes and Cancer. 36(4). 393–401. 61 indexed citations
19.
Knaup, Petra, et al.. (2000). Requirements and design aspects of a data model for a data dictionary in paediatric oncology.. PubMed. 77. 696–700. 2 indexed citations
20.
Ritter, J., Josef Vormoor, Ursula Creutzig, & G. Schellong. (1989). Prognostic significance of auer rods in childhood acute myelogenous leukemia: Results of the studies AML‐BFM‐78 and −83. Medical and Pediatric Oncology. 17(3). 202–209. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Dworzak Breakdown of academic impact, for papers by Selina M. Luger Breakdown of academic impact, for papers by Alan S. Gamis Breakdown of academic impact, for papers by Anjali S. Advani Breakdown of academic impact, for papers by Dan Douer Breakdown of academic impact, for papers by Meir Wetzler Breakdown of academic impact, for papers by Joseph Brandwein Breakdown of academic impact, for papers by Norbert Ifrah Breakdown of academic impact, for papers by Norbert Vey Breakdown of academic impact, for papers by Peter A. Cassileth
Rankless by CCL
2026